Format

Send to

Choose Destination
See comment in PubMed Commons below
Transplant Proc. 2010 Nov;42(9):3673-8. doi: 10.1016/j.transproceed.2010.08.034.

Reversible cardiomyopathies--a review.

Author information

1
Department of Internal Medicine, Mount Sinai Hospital, New York, NY 10029, USA. christopher.j.huffman@gmail.com

Abstract

End-stage renal disease, cirrhosis, obesity, tachycardia, and extreme stress have all been shown to result in impaired left ventricular function. It is becoming clear, however, that the cardiomyopathies associated with these states are reversible after resolution of the underlying process. In this article, we present the current data demonstrating that renal transplantation, liver transplantation, and bariatric surgery can lead to reversal of uremic, cirrhotic, and obesity cardiomyopathies, respectively. We also discuss the reversibility of tachycardia-induced cardiomyopathy after radiofrequency ablation or pharmacologic therapy for rate or rhythm control and the reversibility of stress-induced cardiomyopathy with supportive care.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center